Search for Clinical Trial Results

Explore a wide range of ongoing clinical trials and research studies. Stay updated on the latest healthcare advancements and medical breakthroughs. Learn how you can participate in medical research to contribute to scientific progress

AL Amyloidosis - 146 Studies Found

Status Study
NOT_YET_RECRUITING Study Name: Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Condition:
Date: 2023-06-02
Interventions: Undergo bone marrow biopsy
Not yet recruiting Study Name: Study in Subjects With Light Chain (AL) Amyloidosis
Condition: AL Amyloidosis
Date: 2017-04-28
Interventions: Drug: NEOD001 humanized monoclonal antibody
Not yet recruiting Study Name: Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis
Condition: Amyloidosis Immunoglobulin Light Chain Deposition
Date: 2017-04-21
Interventions: Drug: Bortezomib Given SC
Recruiting Study Name: Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Condition: AL Amyloidosis
Date: 2016-12-12
Interventions: Drug: Venetoclax Venetoclax at
Not yet recruiting Study Name: Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
Condition: Amyloidosis; Systemic
Date: 2016-11-18
Interventions: Drug: Propylene Glycol-Free Melphalan Hydrochloride Intravenous Propylene Glycol-Free Melphalan Hydrochl
Active, not recruiting Study Name: Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
Condition: Multiple Myeloma Amyloidosis
Date: 2016-09-19
Interventions: Device: Melphalan Drug: Pegfilgrastim
Recruiting Study Name: Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis
Condition: Amyloidosis
Date: 2016-06-22
Interventions: Drug: Daratumumab
Recruiting Study Name: Daratumumab for the Treatment of Patients With AL Amyloidosis
Condition: AL Amyloidosis
Date: 2016-06-14
Interventions: Drug: daratumumab Daratumumab by IV infusion once weekly for two months, then every 2 weeks for four mon
Recruiting Study Name: A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
Condition: Plasma Cell Dyscrasia Monoclonal Gammopathy
Date: 2016-04-11
Recruiting Study Name: Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
Condition: Amyloidosis
Date: 2016-03-14
Interventions: Other: blood collection Other: bone marrow
Page 1 of 15
Next >>>